Jie Xu Selected Research

phosphatidylglucose

1/2021

Exogenous phosphatidylglucoside alleviates cognitive impairment by improvement of neuroinflammation, and neurotrophin signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Xu Research Topics

Disease

241	Neoplasms (Cancer) 12/2022 - 12/2002
77	Inflammation (Inflammations) 11/2022 - 04/2002
46	Infections 11/2022 - 12/2009
34	Neoplasm Metastasis (Metastasis) 05/2022 - 04/2009
33	Stroke (Strokes) 11/2022 - 02/2009
29	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2005
29	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 04/2005
28	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2008
28	Carcinogenesis 01/2022 - 10/2008
27	Insulin Resistance 03/2022 - 05/2008
24	Ischemic Stroke 11/2022 - 06/2011
24	Obesity 03/2022 - 09/2009
21	Atherosclerosis 05/2022 - 04/2009
21	Type 2 Diabetes Mellitus (MODY) 04/2022 - 07/2009
20	Osteosarcoma (Osteogenic Sarcoma) 08/2022 - 09/2016
20	Mitochondrial Diseases (Mitochondrial Disease) 05/2022 - 04/2007
20	Lung Neoplasms (Lung Cancer) 05/2022 - 09/2007
20	Stomach Neoplasms (Stomach Cancer) 01/2021 - 08/2008
16	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 12/2002
15	Necrosis 07/2022 - 12/2002
15	Hypertension (High Blood Pressure) 01/2022 - 02/2009
14	Carcinoma (Carcinomatosis) 12/2022 - 05/2008
14	Transient Ischemic Attack 11/2022 - 01/2013
14	Glioma (Gliomas) 05/2022 - 10/2002
13	Colonic Neoplasms (Colon Cancer) 05/2022 - 01/2013
13	Fibrosis (Cirrhosis) 01/2022 - 08/2003
13	Disease Progression 07/2021 - 05/2006
12	Pain (Aches) 12/2022 - 06/2008
12	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 08/2015
12	Non-alcoholic Fatty Liver Disease 03/2022 - 01/2010
12	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 04/2005
12	Diabetes Mellitus 01/2022 - 11/2011
11	Liver Neoplasms (Liver Cancer) 12/2022 - 07/2008
11	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 04/2014
11	Lymphoma (Lymphomas) 03/2022 - 01/2014
11	Wounds and Injuries (Trauma) 02/2022 - 07/2004
10	Hypoxia (Hypoxemia) 01/2022 - 03/2013
10	Asthma (Bronchial Asthma) 10/2020 - 04/2002
9	Body Weight (Weight, Body) 04/2022 - 02/2009
9	Hemorrhage 04/2022 - 05/2008
9	Fatty Liver 03/2022 - 01/2010
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2008
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2013
9	Hyperglycemia 01/2021 - 12/2009
9	Chronic Hepatitis B 01/2017 - 12/2006
8	Thrombosis (Thrombus) 04/2022 - 01/2017
8	Pneumonia (Pneumonitis) 04/2022 - 11/2002
8	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022 - 06/2014

Drug/Important Bio-Agent (IBA)

105	Proteins (Proteins, Gene)FDA Link 08/2022 - 12/2002
52	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2006
32	MicroRNAs (MicroRNA)IBA 04/2022 - 07/2009
29	Pharmaceutical PreparationsIBA 12/2022 - 01/2013
28	Biological ProductsIBA 05/2022 - 05/2012
27	LipidsIBA 04/2022 - 01/2010
27	Insulin (Novolin)FDA Link 04/2022 - 09/2004
23	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 02/2012
22	Messenger RNA (mRNA)IBA 01/2022 - 10/2005
19	CytokinesIBA 01/2021 - 09/2005
18	Therapeutic UsesIBA 05/2022 - 02/2009
18	CateninsIBA 05/2022 - 05/2012
17	Peptides (Polypeptides)IBA 08/2022 - 12/2002
16	Long Noncoding RNAIBA 01/2022 - 10/2013
14	oxidized low density lipoproteinIBA 11/2022 - 06/2011
14	RNA (Ribonucleic Acid)IBA 04/2022 - 10/2002
14	Blood Glucose (Blood Sugar)IBA 03/2022 - 10/2012
14	LigandsIBA 01/2022 - 01/2009
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2005
13	Estrogens (Estrogen)FDA Link 01/2022 - 03/2008
12	Phosphotransferases (Kinase)IBA 06/2022 - 11/2007
12	CholesterolIBA 11/2021 - 12/2011
12	Amyloid (Amyloid Fibrils)IBA 01/2021 - 10/2010
11	AntigensIBA 01/2022 - 04/2010
11	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2017
10	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 09/2009
10	Sucrose (Saccharose)IBA 03/2022 - 10/2015
10	AntioxidantsIBA 01/2022 - 01/2010
10	Retinaldehyde (Retinal)IBA 01/2022 - 01/2013
10	VaccinesIBA 10/2021 - 05/2007
10	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2013
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 02/2009
10	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 01/2014
10	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 12/2002
10	Antiviral Agents (Antivirals)IBA 10/2017 - 01/2010
9	CalciumIBA 03/2022 - 11/2013
9	Histones (Histone)IBA 01/2022 - 05/2008
9	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2005
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 03/2007
9	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2004
9	Neuroprotective AgentsIBA 06/2020 - 10/2008
8	Cyclin D1IBA 05/2022 - 04/2016
8	Caspase 3 (Caspase-3)IBA 03/2022 - 05/2008
8	Adenosine Triphosphate (ATP)IBA 02/2022 - 12/2008
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2017
8	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022 - 08/2016

Therapy/Procedure

136	Therapeutics 12/2022 - 02/2006
22	Drug Therapy (Chemotherapy) 08/2022 - 11/2009
20	Immunotherapy 01/2022 - 01/2017
10	Aftercare (After-Treatment) 11/2022 - 10/2015
8	Transplantation 01/2022 - 02/2009
8	Secondary Prevention 01/2022 - 01/2013